Back to 
Walleye Capital LLC
Walleye Capital LLC
VVOS
Showing 0 of 4 quarters
Position history for Walleye Capital LLC's holdings in Vivos Therapeutics, Inc.
No. Walleye Capital exited its VVOS (Vivos Therapeutics) position in Q3 2021. Its Q2 2021 13F listed 150,000 shares worth $743,000. Walleye Capital first reported VVOS in Q4 2020 and held it in 2 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of VVOS: Royce & Associates LP, Russell Investments Group, Ltd.